XGN - Exagen signals $65M-$70M revenue target for 2025 while advancing new biomarker launches
2025-11-04 15:57:15 ET
More on Exagen
- Exagen Inc. (XGN) Q3 2025 Earnings Call Transcript
- Exagen's Momentum Meets Execution Risks: Why I Choose To HOLD For Now
- Exagen GAAP EPS of -$0.31 misses by $0.15, revenue of $17.24M beats by $0.34M
- Seeking Alpha’s Quant Rating on Exagen
- Historical earnings data for Exagen